RespiratoryAVAlliance

[RespiratoryAVAlliance @RespAVAlliance]

Expanding the services and medications that HSA-eligible health plans can cover before patients meet their deductible could help improve health outcomes and lower healthcare costs. This @WSJ op-ed makes the case for updating HSA rules: https://t.co/85KBzp0kgo

[RespiratoryAVAlliance @RespAVAlliance]

HSA-eligible plans should have more flexibility to cover care before patients meet their deductible. This @WSJ op-ed highlights how updating the rules could help lower healthcare costs: https://t.co/85KBzoZMqQ

[RespiratoryAVAlliance @RespAVAlliance]

For people managing chronic conditions, a COVID-19 infection can disrupt everyday life at home, work, and beyond. Early access to antivirals can help prevent severe illness and support recovery. Learn more: https://t.co/kx0fGtMttM

[RespiratoryAVAlliance @RespAVAlliance]

Preventing severe COVID-19 does not end when symptoms begin. For people at higher risk, early antiviral treatment can help keep illness from becoming more serious. Read why treatment access belongs in the prevention conversation: https://t.co/kx0fGtMttM

[RespiratoryAVAlliance @RespAVAlliance]

COVID-19 can make chronic conditions harder to manage. For people at higher risk, early antiviral treatment can help prevent more severe illness and longer-term complications. Learn why timely, affordable access matters: https://t.co/kx0fGtLVEe

[RespiratoryAVAlliance @RespAVAlliance]

For those with pre-existing conditions, a COVID-19 diagnosis can mean severe complications. Antivirals can help lessen illness, but unexpected costs can create hesitation when quick action matters most. Learn more: https://t.co/YvrmoztDE2

[RespiratoryAVAlliance @RespAVAlliance]

For high-risk patients, COVID-19 antivirals can help prevent serious complications, but only if treatment starts quickly. Cost uncertainty and high copays make patients hesitate, wasting precious time. There shouldn't be barriers between patients and care: https://t.co/L0weWwXuGU

[RespiratoryAVAlliance @RespAVAlliance]

COVID-19 is on the rise across the US, but there are treatment options available. For older adults and those with chronic medical issues, antiviral treatment can help prevent serious illness. More from @Forbes: https://t.co/lrTSv3haE7

[RespiratoryAVAlliance @RespAVAlliance]

Para pacientes como David, comprender lo que cubre seguro médico lleva tiempo. Los antivirales contra el COVID-19 debe administrarse con rapidez, pero los costos retrasan la atención médica. Cuando el tiempo no sobra, el acceso debe ser simple y económico: https://t.co/r6ccqVjDpF

[RespiratoryAVAlliance @RespAVAlliance]

For those with pre-existing conditions, a COVID-19 diagnosis can mean severe complications. Antivirals can help lessen illness, but unexpected costs can create hesitation when quick action matters most. Learn more: https://t.co/YvrmoztDE2

[RespiratoryAVAlliance @RespAVAlliance]

Los deducibles y altos copagos afectan a los pacientes con Medicare que buscan antivirales contra el COVID-19. Este tratamiento puede ayudar a prevenir complicaciones, pero debe iniciarse rápidamente. Infórmate más: https://t.co/IzmTxEkXik

[RespiratoryAVAlliance @RespAVAlliance]

High deductibles & co-pays can make those with Medicare hesitate to fill a prescription for a COVID-19 antiviral. Antiviral treatments can help prevent serious illness but need to be started quickly. See how barriers can prevent easy antiviral access: https://t.co/8nLQeJxPuG

[RespiratoryAVAlliance @RespAVAlliance]

For people with chronic conditions, prevention is more than an annual checkup. It means staying healthy, avoiding complications, and accessing treatment quickly when new risks arise. High deductibles should not stand in the way of timely care: https://t.co/k3JI58jkWe

[RespiratoryAVAlliance @RespAVAlliance]

Barriers like high deductibles can make preventive care like COVID-19 antivirals harder to access. See how information barriers can limit timely access to COVID-19 antivirals here: https://t.co/OH91uGybbG

[RespiratoryAVAlliance @RespAVAlliance]

Los obstáculos como los altos deducibles pueden dificultar el acceso a la atención preventiva, como los antivirales contra el COVID-19. Descubre aquí cómo las barreras informativas pueden limitar el acceso oportuno a los antivirales contra el COVID-19: https://t.co/DpLX00ki4X

[RespiratoryAVAlliance @RespAVAlliance]

El tiempo es clave para las personas con enfermedades preexistentes que dan positivo en la prueba del COVID-19. Los antivirales pueden ayudar, pero el acceso, la capacidad de pago y el conocimiento son fundamentales. Más información: https://t.co/JGmBdfMOWy

[RespiratoryAVAlliance @RespAVAlliance]

Time is of the essence for those with pre-existing conditions who test positive for COVID-19. Antivirals can help, but access, affordability, and awareness are key. Learn more: https://t.co/bjsjMX5cBy

[RespiratoryAVAlliance @RespAVAlliance]

Timing matters. A recent study found early antiviral use was linked to a lower risk of long COVID and a better chance of returning to usual health after COVID-19. If you’re sick, ask about treatment options early. Learn more: https://t.co/xBMnEJokMw

[RespiratoryAVAlliance @RespAVAlliance]

Antivirals can do more than help treat COVID-19 symptoms. Early use can also help prevent more serious illness, shorten the duration of illness, and may lower the risk of long COVID. Talk to a healthcare provider as soon as symptoms start. Learn more: https://t.co/xBMnEJokMw

[RespiratoryAVAlliance @RespAVAlliance]

New research suggests that early antiviral treatment for COVID-19 may support recovery and reduce the risk of long COVID. If you test positive, don’t wait to ask a healthcare provider whether treatment is right for you. Learn more: https://t.co/xBMnEJokMw